Poloxamer 188 (Phrixus Pharmaceuticals)

泊洛沙姆188(Phrixus Pharmaceuticals)

Report date: 2023/01/12 20:00:37

Base Information

Drug NamePoloxamer 188 (Phrixus Pharmaceuticals)
Drug Alias NameCarmeseal-HFCarmeseal-MDCarmesealP-188P-188-NF
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBlood cells modulators
TargetsNot applicable
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCytrx Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhrixus Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophy, Duchenne

Other Information

ATC CodeN/A
Related LinksN/A